Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amylin, Novo Nordisk buck downward trend
Amylin, Novo Nordisk buck downward trend
Amylin, Novo Nordisk buck downward trend
Submitted by
admin
on April 1, 2009 - 3:50pm
Source:
Marketwatch
News Tags:
Amylin
Novo Nordisk
Celgene
Eli Lilly
Alkermes
AstraZeneca
Headline:
Amylin, Novo Nordisk buck downward trend
Do Not Allow Advertisers to Use My Personal information
